Taoreed Adegoke Azeez, Olusegun Adetomiwa Adediran, Emmanuel Chinedu Eguzozie, Ejemhen Ekhaiyeme Pan Am J Ophthalmol 2021, 3:17 (18 May 2021) DOI:10.4103/pajo.pajo_82_21
Introduction: The prevalence of diabetes mellitus and its complications is rising globally. Diabetic retinopathy is one of the most common microvascular complications of diabetes and is the most common cause of blindness in adults globally. The aims of this study were to determine the pooled prevalence of diabetic retinopathy in Nigeria and to identify the associated risk factors.
Methods: Medical databases including PubMed, Google Scholar, African Journals online, Cochrane library, EMBASE, and SCOPUS were searched for studies on diabetic retinopathy in Nigeria between the years 2000 and 2020 using the MESH terms “diabetic retinopathy,” “prevalence,” “risk factors,”, “Nigeria.” The gray literature was also searched. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were strictly adhered to in selecting the studies. The outcome variables of interest were prevalence of diabetic retinopathy in Nigeria as well as risk factors associated with diabetic retinopathy. The Newcastle-Ottawa scale was used to assess the quality and bias of the selected studies. Statistical analyses were performed using Stata version 14.3. DerSimonian and Laird random-effect model was used. Heterogeneity was assessed using the I2 statistic.
Results: Twenty studies met the eligibility criteria and they were selected for the studies. The total sample size was 3299. I2 statistic was 99%, which suggests a high level of heterogeneity among the selected studies. Using the random-effect model, the pooled prevalence of diabetic retinopathy in Nigeria was 21.3% (95% confidence interval 21.1–21.5). The most common risk factors for diabetic retinopathy in Nigeria were duration of diabetes, poor glycemic control, and hypertension.
Conclusion: The prevalence of diabetic retinopathy in Nigeria is high and there is a need to improve the glycemic control of patients with diabetes so as to prevent or delay its onset.
|